Neurology
Huntington’s Gets Another Chance at Proof
ASCO 2026 showed how comprehensive genomic solutions are moving from research support to the practical backbone of cancer detection, profiling, monitoring and treatment matching.
Duchenne’s Accelerated Approval Faces Its Test
Neurology Is Trying to Stop Nerves Dying, Not Just Treat What Is Left
MS Has Learnt to Stop Inflammation. It Still Cannot Repair the Damage.
MS Does Not End at the Clinic Door. It Follows People Into Work, Money and Relationships.
For Drug-Resistant Epilepsy, Surgery Should Not Be the Only Door
A Licensing Deal Is Not Access. But It Decides Whether Access Is Possible.
When the Test Says Normal but the Pain Does Not
When Brain Surgery Is Too Risky, Patients Still Need a Molecular Answer
Germany Is Paying the Price for Leaving Tardive Dyskinesia Behind
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.